MARC details
000 -LEADER |
fixed length control field |
03518cam a22003978i 4500 |
001 - CONTROL NUMBER |
control field |
on1298513958 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240726104849.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220224s2022 nyu ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2022006900 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
Modifying agency |
OCLCO |
-- |
OCLCF |
-- |
UKAHL |
-- |
NT |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781685076986 |
Qualifying information |
|
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC271 |
Item number |
.H697 2022 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Sak, Katrin, |
Dates associated with a name |
1975- |
Relator term |
Author |
245 10 - TITLE STATEMENT |
Title |
How plant flavonoids affect the outcome of hormonal and biological cancer therapies : |
Remainder of title |
a handbook for doctors and patients / |
Statement of responsibility, etc. |
Katrin Sak. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
Nova Science Publishers, |
Date of publication, distribution, etc. |
(c)2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
data file |
Source |
rda |
490 0# - SERIES STATEMENT |
Series statement |
Cancer etiology, diagnosis and treatments |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographies and index. |
520 0# - SUMMARY, ETC. |
Summary, etc. |
"Cancer is a steadily increasing public health concern and severe socio-economic burden all over the world. Based on the current statistics of the WHO, almost 10 million people lost their lives due to malignant disorders in 2020, implying that one in every six deaths is due to cancer. In parallel, the global population of cancer survivors is also growing, propelled by advances in early detection, diagnosis and treatment methods, but also by demographic aging. More and more cancer patients today decide to use dietary supplements and herbal products in order to enhance their overall health, delay the progression of disease, augment the outcome of conventional therapies, mitigate diagnosis-related depression and anxiety, and alleviate drug-associated side effects, doing it mostly unbeknownst to their health care providers. Such over-the-counter supplements usually contain diverse flavonoids, such as catechins from green tea extracts, isoflavones from soy products, flavanones from citrus oils or silibinin from milk thistle seeds, just to name a few. A variety of flavonoid-rich products are often consumed concurrently with standard cancer therapies, without anticipating and understanding the potential interactions between plant-derived bioactive flavonoids and clinically used anticancer drugs. In this book, diverse effects of these polyphenolic phytochemicals on hormonal and targeted biological cancer therapies are covered, being a reasoned follow-up to the two previous books Plant Flavonoids Affect Cancer Chemotherapeutic Efficacy: A Handbook for Doctors and Patients (2019) and Dietary Flavonoids Interfere with Cancer Radiotherapy (2019). Besides naturally occurring flavonoids, the impact of flavonoid-rich plant extracts as well as semisynthetic derivatives on anticancer activities of co-administered hormonal and targeted drugs are thoroughly discussed, and some indicative recommendations to patients undergoing hormonal cancer therapies or targeted biological cancer therapies are provided"-- |
Assigning source |
|
530 ## - COPYRIGHT INFORMATION: |
COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
Uniform Resource Identifier |
<a href="b">b</a> |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Flavonoids |
General subdivision |
Therapeutic use. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cancer |
General subdivision |
Treatment. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Flavonoids |
General subdivision |
Physiological effect. |
655 #1 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic Books. |
856 40 - ELECTRONIC LOCATION AND ACCESS |
-- |
Click to access digital title | log in using your CIU ID number and my.ciu.edu password. |
Uniform Resource Identifier |
<a href="httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3171220&site=eds-live&custid=s3260518">httpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3171220&site=eds-live&custid=s3260518</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Online Book (LOGIN USING YOUR MY CIU LOGIN AND PASSWORD) |
DONATED BY: |
|
VENDOR |
EBSCO |
Classification part |
RC. |
PUBLICATION YEAR |
2022 |
LOCATION |
ONLINE |
REQUESTED BY: |
|
-- |
|
-- |
NFIC |
Source of classification or shelving scheme |
|
994 ## - |
-- |
92 |
-- |
NT |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
1 |
b |
Cynthia Snell |
c |
1 |
d |
Cynthia Snell |